Notícias e Atividades da Rani Therapeutics
Presença
Rani Therapeutics é uma empresa listada sob o símbolo RANI (US).
Executivos
Veja o organograma con seus 16 executivos principais
Biografias mais buscadas da Rani Therapeutics
- Talat Imran, Chief Executive Officer
- Andrew Farquharson, Director
- Mir Imran, Executive Chairman of the Board
Criar um alerta
para seguir os movimentos de executivos da Rani Therapeutics.
Biotecnologia
Rani Therapeutics possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).
Popular M&A news in Biotecnologia
- Transcarent and Accolade have merged (publicado em 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
- Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Rani Therapeutics
- Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update - Rani Therapeutics, LLC
- Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results - Rani Therapeutics, LLC
- Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102 - Rani Therapeutics, LLC
- Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC - Rani Therapeutics, LLC
- Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - Rani Therapeutics, LLC
- Rani Therapeutics to Participate in Upcoming Investor Conferences - Rani Therapeutics, LLC
- Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants - Rani Therapeutics, LLC
- Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist - Rani Therapeutics, LLC
- Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit - Rani Therapeutics, LLC
- Rani Therapeutics to Participate in September Investor Conferences - Rani Therapeutics, LLC
- View more press releases Close
Redes sociais sobre Rani Therapeutics
- Rani Therapeutics na Wikipedia, Google News e Yahoo Finance
- Rani Therapeutics na LinkedIn, Twitter e YouTube
